PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1190860
PUBLISHER: Mordor Intelligence | PRODUCT CODE: 1190860
The filter integrity test market is expected to register a CAGR of 4.6% during the forecast period, due to the growing biopharmaceutical industry and the increasing expenditure on R&D activities. According to the Pharmaceutical Researchers and Manufacturers of America (PhRMA), a drug development generally takes 10 to 15 years and it costs on an average of about USD 2.6 billion. Furthermore, in 2016, worldwide spending on R&D by the pharmaceutical and biopharmaceutical companies was around USD 156.7 million. Moreover, in 2017, PhRMA established new criteria according to which there should be a minimum average investment of about USD 200 million per year. Such initiatives are expected to drive the demand for a filter integrity test.
* The automated segment is expected to be a dominant segment in the filter integrity test market, owing to the developing technology in the product and its advantages over manual. It involves no operator, thus minimal or no contamination whereas in manual filter tester handling of the equipment is totally dependent on operators and maintenance of record becomes difficult.
* In 2019, Sartorius AG developed a product Sartocheck® 5 Plus filter integrity tester for downstream processing. It is able to detect human errors, hazardous environments, and improper test set-ups. Also, Air Techniques International introduced 100X Automated Filter Efficiency Tester designed for filter media and cartridges that are involved in pharmaceutical production. Thus, these factors are expected to propel the market in this particular segment.
The North American region is expected to hold a major market share in the global filter integrity test market, due to increasing investments in R&D activities related to pharmaceuticals and biopharmaceuticals. According to the Pharmaceutical Researchers and Manufacturers of America (PhRMA) data of 2016, United States has the highest share of around 58% in terms of R&D expenditure. Furthermore, according to the European Federation of Pharmaceutical Industries and Associations, the R&D expenditure was around 52,418 million USD in United States. Hence, these factors are expected to impact positively on the filter integrity test market.
The filter integrity test market is fragmented and consists of several major players. Some of the companies that are currently dominating the market are Merck KGaA, Sartorius AG, MEISSNER FILTRATION PRODUCTS INC., ThermoFisher Scientific Inc., Donaldson Company, PARKER HANNIFIN CORP., Eaton Corporation PLC, Pall Corporation, 3M, and Filter Integrity Ltd.